|
You are here |
news.mcmaster.ca | ||
| | | | |
www.fda.gov
|
|
| | | | | The FDA amended the emergency use authorization of the Novavax COVID-19 Vaccine, Adjuvanted for use in individuals 12 years of age and older to include the 2023-2024 formula. The updated vaccine addresses currently circulating variants to provide better protection against serious consequences of COV | |
| | | | |
www.cancer.gov
|
|
| | | | | The success of COVID-19 mRNA vaccines could accelerate research on mRNA vaccines to treat cancer. Read about the progress of mRNA cancer vaccines. | |
| | | | |
www.wired.com
|
|
| | | | | Two leading candidates are headed for mass clinical trials, and everything's on the table-including deliberately infecting healthy vaccine volunteers. | |
| | | | |
sjogrens.org
|
|
| | | Interview with Cassandra Calabrese, DO, and member of the Foundation's COVID-19 Vaccination CommitteeThe Sjögren's Foundation understands that many patients continue to have questions about COVID-19, new variants, and the safety and effectiveness of the vaccine. | ||